The global spine biologics market is predicted to reach $2.7 billion by 2024, growing at a 4.4 percent compound annual growth rate, according to a Data Bridge Market Research report.
Here are 18 major market players:
1. Arthrex
2. Cesca Therapeutics
3. DePuy Synthes
4. DMP Spine
5. Exactech
6. K2M
7. Lattice Biologics
8. Medtronic
9. Nuo Therapeutics
10. Nutech
11. NuVasive
12. Orthofix
13. Regen Lab
14. RTI Surgical
15. Stryker
16. Wright Medical
17. X-Spine Systems
18. Zimmer Holdings
More articles on biologics:
Crocodiles may be the future of cartilage repair — 4 things to know about a new technology
UC San Diego scientists derive spinal cord stem cells: 4 insights
Dr. Kevin Pauza certifies 14 spine physicians in Discseel procedure